{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:27:27Z","timestamp":1785774447904,"version":"3.56.0"},"reference-count":24,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In 2018 in France, overall mean health\u2010related out\u2010of\u2010pocket (OOP) expenditures were 214.00\u20ac\/year\/patient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To evaluate OOP expenditures for psoriasis patients in France.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>Observational, cross\u2010sectional, non\u2010comparative, multicentre study in 3000 patients with clinically confirmed psoriasis who responded to a specific digital questionnaire collecting demographic and socio\u2010economic characteristics, assessing the 3 domains (severity, psychosocial impact and past history and interventions) of the patient\u2019s Simplified Psoriasis Index (sa\u2010SPI) and expenditures to manage psoriasis, including OOP. Multivariate linear regression was conducted to search for factors associated with higher OOP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 2681 patients completed the questionnaire and, of those, 2562 provided clinically validated data. Overall, 60% were women; the mean age was 49.4\u00a0\u00b1\u00a014.8\u00a0years. 30% of the patients declared that they suffered from psoriatic arthritis. The final mean sa\u2010SPI core was 10.86\u00a0\u00b1\u00a09.70.<\/jats:p><jats:p>Of these 2562 patients, 243 (9.5%) had severe, 442 (17.3%) moderate and 1877 (73.3%) mild psoriasis. In addition, 932 (36.4%) patients reported facial involvement, 724 (28.25%) genital impairment and 1124 (43.8%) lesions on the limbs.<\/jats:p><jats:p>Mean OOP expenditures to manage psoriasis per patient were 531.00\u20ac, 439.74\u20ac\u00a0\u00b1\u00a0939.85\u20ac for patients with mild, 791.06\u20ac\u00a0\u00b1\u00a01367.67\u20ac with moderate and 1077.64\u20ac\u00a0\u00b1\u00a01680.14\u20ac for patients with severe psoriasis. For patients with psoriasis in the genital area, the median amount of expenditures (251.17\u20ac; CI95% [138.35;363.99]) was significantly higher than that for the face (183.85\u20ac; CI95% [78.76;288.94]) or limbs (199.96\u20ac; CI95% [93.77;306.15); (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001).<\/jats:p><jats:p>More than 90% of the patients had OOP expenditures for over\u2010the\u2010counter products (97.5%) and alternative care (92.0%), especially for emollients and\/or hydrating products.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In France, in 2019, OOP expenditures to manage psoriasis were on average more than twice as high as the overall mean health\u2010related OOP expenditures estimated by the French Health Agency in 2018. These results should lead health authorities to review certain standards of healthcare reimbursement.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.17000","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T05:56:50Z","timestamp":1603087010000},"page":"912-918","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Out\u2010of\u2010pocket expenditures in France to manage psoriasis in adult patients: results from an observational, cross\u2010sectional, non\u2010comparative, multicentre study"],"prefix":"10.1111","volume":"35","author":[{"given":"M.\u2010A.","family":"Richard","sequence":"first","affiliation":[{"name":"Dermatology Department University Hospital Timone Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of Dermatology Toulouse University and CHU Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"De Pouvourville","sequence":"additional","affiliation":[{"name":"ESSEC Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jullien","sequence":"additional","affiliation":[{"name":"Service de Dermatologie H\u00f4pital Edouard Herriot Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5780-1827","authenticated-orcid":false,"given":"E.","family":"Mahe","sequence":"additional","affiliation":[{"name":"Department of Dermatology H\u00f4pital Victor Dupouy Argenteuil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bachelez","sequence":"additional","affiliation":[{"name":"Department of Dermatology H\u00f4pital Saint Louis Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Seneschal","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Paediatric Dermatology National Reference Center for Rare Skin Diseases Saint\u2010Andr\u00e9 Hospital University Hospital of Bordeaux Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8088-7059","authenticated-orcid":false,"given":"L.","family":"Misery","sequence":"additional","affiliation":[{"name":"Department of Dermatology CHRU de Brest Brest France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Aubert","sequence":"additional","affiliation":[{"name":"Dermatology France Patient Advocacy Group France Psoriasis Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Reguiai","sequence":"additional","affiliation":[{"name":"Department of Dermatology Polyclinique de Courlancy Reims France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Shourick","sequence":"additional","affiliation":[{"name":"Emma Clinic Fontentay sous Bois France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-2479","authenticated-orcid":false,"given":"C.","family":"Taieb","sequence":"additional","affiliation":[{"name":"Dermatological Clinics Charles Nicolle Hospital Rouen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5734-0255","authenticated-orcid":false,"given":"P.","family":"Joly","sequence":"additional","affiliation":[{"name":"Dermatology Henri Mondor Hospital Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ezzedine","sequence":"additional","affiliation":[{"name":"Department of Dermatology, EA EpiDermE (Epid\u00e9miologie en Dermatologie et Evaluation des Th\u00e9rapeutiques), UPEC\u2010Universit\u00e9 Paris\u2010Est H\u00f4pital Henri Mondor Creteil France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,12,8]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2006.07.006"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.02.039"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.40.4.366"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39494"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14959"},{"key":"e_1_2_6_7_1","first-page":"92","article-title":"Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double\u2010blind, vehicle\u2010controlled trial","volume":"12","author":"Menter A","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e6712"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12443"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12058"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2014.2294"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15581"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.138"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.318"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3102"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1910366"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1690622"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1744505"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2010.550911"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14543"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0960.2002.00611.x"},{"key":"e_1_2_6_22_1","first-page":"85","article-title":"Estimation of cost\u2010of\u2010illness in patients with psoriasis in Switzerland","volume":"140","author":"Navarini AA","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.12968\/bjcn.2013.18.4.174"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13354"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.12.018"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.17000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.17000","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.17000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T17:11:10Z","timestamp":1693588270000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.17000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1111\/jdv.17000"],"URL":"https:\/\/doi.org\/10.1111\/jdv.17000","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,8]]},"assertion":[{"value":"2020-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}